Cargando…
The Role of the Crosstalk Between Gut Microbiota and Immune Cells in the Pathogenesis and Treatment of Multiple Myeloma
Around 10% of all hematologic malignancies are classified as multiple myeloma (MM), the second most common malignancy within that group. Although massive progress in developing of new drugs against MM has been made in recent years, MM is still an incurable disease, and every patient eventually has r...
Autores principales: | Jasiński, Marcin, Biliński, Jarosław, Basak, Grzegorz W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009288/ https://www.ncbi.nlm.nih.gov/pubmed/35432306 http://dx.doi.org/10.3389/fimmu.2022.853540 |
Ejemplares similares
-
The Role of the Gut Microbiome in Pathogenesis, Biology, and Treatment of Plasma Cell Dyscrasias
por: Jasiński, Marcin, et al.
Publicado: (2021) -
The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease
por: Biliński, Jarosław, et al.
Publicado: (2022) -
Perspectives for the Use of CAR-T Cells for the Treatment of Multiple Myeloma
por: Jasiński, Marcin, et al.
Publicado: (2021) -
Crosstalk Between Gut Microbiota and Innate Immunity and Its Implication in Autoimmune Diseases
por: Jiao, Yuhao, et al.
Publicado: (2020) -
Crosstalk between the gut microbiota and innate lymphoid cells in intestinal mucosal immunity
por: Guo, Yuling, et al.
Publicado: (2023)